Whole-genome landscapes of major melanoma subtypes
Publications
VIDEO: Speaker offers updates on combinations, sequencing of immunotherapies for melanoma
NEW YORK — Michael A. Postow, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, addressed the use of immune checkpoint inhibitors at HemOnc Today Melanoma and Cutaneous Malignancies.
VIDEO: Managing immune-related adverse events requires multidisciplinary approach
NEW YORK — Kathleen M. Madden, MSN, FNP, AOCNP, APHN, a nurse practitioner at the Laura and Isaac Perlmutter Cancer Center at the NYU Langone Medical Center, discussed best practices in identifying and managing immune-related adverse events at HemOnc Today Melanoma and Cutaneous Malignancies.
Molecule identified that helps give resident T cells in the skin their anti-cancer punch
The molecule CD103 is key to the long-term residence of T cells in the skin and to their anti-tumor function, report a team of researchers at the Medical University of South Carolina (MUSC) and the Dartmouth-Hitchcock Norris Cotton Cancer Center In the April 14, 2017 Science Immunology.